Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects

被引：4
|
作者：
Ravel-Chapuis, Aymeric [1 ,2 ]
Jasmin, Bernard J. [1 ,2 ]
机构：
[1] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada
[2] Univ Ottawa, Fac Med, Er Poulin Ctr Neuromuscular Dis, Ottawa, ON, Canada
来源：
TRENDS IN MOLECULAR MEDICINE | 2022年 / 28卷 / 06期
关键词：
D O I：
10.1016/j.molmed.2022.04.004
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Myotonic dystrophy type 1 (DM1) is a multisystemic disorder for which there is no cure. In recent years, progress has been made in defining disease mechanisms and in developing novel therapies, especially for skeletal muscle defects. Here, we highlight the potential of activating AMP-activated protein kinase (AMPK) with different approaches in combinatorial therapies.
引用
收藏
页码：439 / 442
页数：4
相关论文
共 50 条
  • [1] Preferential changes of skeletal muscle echogenicity in myotonic dystrophy type 1
    Takamatsu, N.
    Sogawa, K.
    Nodera, H.
    Hashiguchi, S.
    Osaki, Y.
    Saito, M.
    Mori, A.
    Izumi, Y.
    Kaji, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (02) : 366 - 373
  • [2] MRI of Tibialis Anterior Skeletal Muscle in Myotonic Dystrophy Type 1
    Cote, Chantal
    Hiba, Bassem
    Hebert, Luc J.
    Vial, Christophe
    Remec, Jean Francois
    Janier, Marc
    Puymirat, Jack
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2011, 38 (01) : 112 - 118
  • [3] TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
    Bose, Francesca
    Renna, Laura Valentina
    Fossati, Barbara
    Arpa, Giovanni
    Labate, Valentina
    Milani, Valentina
    Botta, Annalisa
    Micaglio, Emanuele
    Meola, Giovanni
    Cardani, Rosanna
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [4] Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2
    Cardani, Rosanna
    Bugiardini, Enrico
    Renna, Laura V.
    Rossi, Giulia
    Colombo, Graziano
    Valaperta, Rea
    Novelli, Giuseppe
    Botta, Annalisa
    Meola, Giovanni
    PLOS ONE, 2013, 8 (12):
  • [5] Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1
    Morriss, Ginny R.
    Rajapakshe, Kimal
    Huang, Shixia
    Coarfa, Cristian
    Cooper, Thomas A.
    HUMAN MOLECULAR GENETICS, 2018, 27 (16) : 2789 - 2804
  • [6] Muscle MRI in myotonic dystrophy type 1
    Garibaldi, M.
    Bucci, E.
    Cristiano, L.
    Morino, S.
    Fionda, L.
    Vanoli, F.
    Leonardi, L.
    Pennisi, E.
    Tartaglione, T.
    Petrucci, A.
    Antonini, G.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S112 - S112
  • [7] microRNA-mRNA expression profiles in the skeletal muscle of myotonic dystrophy type 1
    Li, Mao
    Li, Yifan
    Wang, Zhanjun
    Cui, Fang
    Yang, Fei
    Wang, Hongfen
    Shi, Qiang
    Huang, Xusheng
    NEUROLOGICAL RESEARCH, 2024, 46 (07) : 613 - 625
  • [8] Biomarkers in skeletal muscle rehabilitation in myotonic dystrophy
    Angelini, C.
    Fritegotto, C.
    Cudia, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E39 - E39
  • [9] Muscle phenotype in patients with myotonic dystrophy type 1
    Andersen, Grete
    Orngreen, Mette C.
    Preisler, Nicolai
    Colding-Jorgensen, Eskild
    Clausen, Torben
    Duno, Morten
    Jeppesen, Tina D.
    Vissing, John
    MUSCLE & NERVE, 2013, 47 (03) : 409 - 415
  • [10] Decreased skeletal muscle chloride current density in myotonic dystrophy type 1 (DM1)
    Lueck, JD
    Thornton, CA
    Dirksen, RT
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 420A - 420A
12345